McDonald Board of Directors Issues Statement in Response to Carl Icahn
McDonald s has confirmed that it has nominated two nominees to stand for the 2022 Annual Meeting of the US Food and Drug Administration (FDA) nominations, which will take place in January. Why is it a threat to shareholder action?
Source: prnewswire.comPublished on 2022-02-20
Related news
- Overclaim or Exaggerate at Your Peril - Ecoveritas
- Natural gas group under investigation in Canada
- ESG Waterloo moment
- Exxon , Chevron CEOs Excoriated in 7 - Hour D . C . Climate H ...
- Hennessy Advisors , Inc . Reports Quarterly Earnings Per Share and Announces Quarterly Dividend
- Competition Bureau investing Canadian Gas Association claims after complaint | iNFOnews
- Azenta Publishes its Environmental , Social , & Governance ( ESG ) Report
- Verisk Analytics , Inc . Prices Offering of Senior Notes
- Isleworth Healthcare Acquisition Corp . Announces Pricing of Upsized $180 , 000 , 000 Initial Public Offering
- Four common signs of greenwashing
- Going green with sovereign bonds - The Hindu BusinessLine
- Why sustainability and ESG are critical for firms
- Press Release - MINING . COM
- MSC LNG World Europa Starts Sailing the Mediterranean
- Rab Unveils Nutrition Label for Sustainability : Material Facts